BREANNA TALBERT: Open Payments
NPI 1992428643 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,273 in 63 payments from 17 companies in 2025. Trend: 2023 $194 · 2024 $532 · 2025 $1,273
Food & beverage: $1,273
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $265 |
| ABBVIE INC. | 15 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $185 |
| Celltrion USA Inc. | 5 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| Phathom Pharmaceuticals, Inc. | 4 | $77 |
| Lilly USA, LLC | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| Ipsen Biopharmaceuticals, Inc | 2 | $51 |
| QOL Medical, LLC | 2 | $31 |
Products named: TREMFYA, RINVOQ, EOHILIA, VEGZELMA, ENTYVIO, XIFAXAN, VOQUEZNA, DUPIXENT.
Industry payments across IA — which companies pay providers there.
